KLK3 and prostate carcinoma: Men diagnosed with prostate cancer shows a significantly elevated PSA level (111.06 ± 214.26) compared to controls (2.80 ± 1.10) with a highly significant p-value (< 0.0001), further exemplifying the use of PSA as a valuable diagnostic parameter.